How big is the Neurodegenerative Disease Market?

The Neurodegenerative Disease Market size is expected to reach USD 55.12 billion in 2024 and grow at a CAGR of 7.14% to reach USD 77.82 billion by 2029. Read More

What is the current Neurodegenerative Disease Market size?

In 2024, the Neurodegenerative Disease Market size is expected to reach USD 55.12 billion. Read More

Who are the key players in Neurodegenerative Disease Market?

Boehringer Ingelheim International GmbH, UCB SA, Novartis AG, Teva Pharmaceutical and Merck & Co Inc. are the major companies operating in the Neurodegenerative Disease Market. Read More

Which is the fastest growing region in Neurodegenerative Disease Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Neurodegenerative Disease Market?

In 2024, the North America accounts for the largest market share in Neurodegenerative Disease Market. Read More

What years does this Neurodegenerative Disease Market cover, and what was the market size in 2023?

In 2023, the Neurodegenerative Disease Market size was estimated at USD 51.18 billion. The report covers the Neurodegenerative Disease Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Neurodegenerative Disease Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Neurodegenerative Disease Market Share

Statistics for the 2023 & 2024 Neurodegenerative Disease market share, created by Mordor Intelligence™ Industry Reports. Neurodegenerative Disease share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Neurodegenerative Disease Industry

The market is semi-consolidated due to the presence of a few major market players. The major players adopt strategic methods such as mergers and acquisitions, partnerships and collaborations, investments in research and development activities, and new product launches to withstand the global competitive rivalry. Some major market players are AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceuticals, Novartis AG, and UCB SA.